GlassScriptPhysician profile
Naresh Purohit
NPI 1396759452
$1,577.80
in general payments reported to CMS, 2019-2025
23 companies · $399 in 2025
The $399 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $73.52 · 2021: $250 · 2022: $101 · 2023: $121 · 2024: $485 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,005.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $547.63 | 2021-2025 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $179.02 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Recordati_rare_diseases_inc. | $124.95 | 2025 | Sylvant |
| Pfizer INC. | $109.85 | 2019-2023 | |
| Corium, LLC | $107.72 | 2023-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $88.14 | 2019-2025 | Enflonsia, Vaxneuvance, Proquad |
| Takeda Pharmaceuticals U.S.A., INC. | $82.52 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $49.13 | 2019-2024 | |
| Adlon Therapeutics L.P. | $45.04 | 2020-2021 | |
| Genentech USA, INC. | $29.24 | 2020 | |
| Pharming Healthcare, INC. | $26.93 | 2023 | Ruconest |
| Mckesson Medical-Surgical, INC. | $25.43 | 2025 | |
| Phadia US INC. | $18.90 | 2024 | Immunocap |
| Sobi, INC | $18.77 | 2021 | |
| Verrica Pharmaceuticals INC. | $16.66 | 2024 | Ycanth |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $16.53 | 2022 | |
| Sanofi Pasteur INC. | $16.17 | 2019 | |
| Abbott Laboratories | $14.78 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $14.61 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $13.62 | 2021 | |
| Seqirus USA INC | $13.49 | 2025 | Flucelvax |
| Shire North American Group INC | $11.68 | 2019 | |
| Vivaquant INC, Dba Rhythm Express | $6.99 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naresh Purohit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.